慢性髓性白血病中不同BCR-ABL1转录本类型的比例:一项国际概览
该国际概览基于45个国家45503例新诊断慢性髓性白血病(CML)患者,发现e13a2与e14a2(含共表达)比例分别为37.9%和62.1%,且与性别、年龄相关并在全球分布不均;罕见转录本占1.93%,其比例亦与性别和年龄相关。
要点
- e13a2与e14a2(含共表达)比例分别为37.9%和62.1%,男性e13a2更常见(39.2% vs 36.2%)。
- e13a2比例随年龄增长而下降,从儿童和青少年的39.6%降至≥80岁患者的31.6%。
- 罕见转录本见于666/34561例(1.93%),女性2.27%高于男性1.69%,并随年龄增长而升高。
核心结论
- 不同BCR-ABL1转录本类型的比例差异并非偶然,转录本类型是被怀疑对治疗反应、治疗结局和无治疗缓解率具有预后重要性的变量。
研究设计与样本
- 国际概览,纳入45个国家报告的45503例新诊断慢性髓性白血病(CML)患者。
主要发现
- e13a2(又称b2a2)和e14a2(又称b3a2,包括共表达e14a2和e13a2的病例)的比例分别为37.9%和62.1%。
- e13a2在男性中的比例为39.2%,高于女性的36.2%;e13a2比例从儿童和青少年的39.6%降至≥80岁患者的31.6%。
- 罕见转录本见于666/34561例患者(1.93%),女性为2.27%,男性为1.69%;罕见转录本比例从儿童和青少年的1.79%升至≥80岁患者的3.84%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There are different BCR-ABL1 fusion genes that are translated into proteins that are different from each other, yet all leukemogenic, causing chronic myeloid leukemia (CML) or acute lymphoblastic leukemia. Their frequency has never been systematically investigated. In a series of 45503 newly diagnosed CML patients reported from 45 countries, it was found that the proportion of e13a2 (also known as b2a2) and of e14a2 (also known as b3a2), including the cases co-expressing e14a2 and e13a2, was 37.9% and 62.1%, respectively. The proportion of these two transcripts was correlated with gender, e13a2 being more frequent in males (39.2%) than in females (36.2%), was correlated with age, decreasing from 39.6% in children and adolescents down to 31.6% in patients ≥ 80 years old, and was not constant worldwide. Other, rare transcripts were reported in 666/34561 patients (1.93%). The proportion of rare transcripts was associated with gender (2.27% in females and 1.69% in males) and with age (from 1.79% in children and adolescents up to 3.84% in patients ≥ 80 years old). These data show that the differences in proportion are not by chance. This is important, as the transcript type is a variable that is suspected to be of prognostic importance for response to treatment, outcome of treatment, and rate of treatment-free remission.
引用
- Baccarani M, Castagnetti F, Gugliotta G, et al. The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview. Leukemia. 2019. PMID: 30675008. doi:10.1038/s41375-018-0341-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。